For drug-resistant cancer
For drug-resistant cancer
World-class expertise in AI and computational drug discovery. Deep expertise in experimental chemistry and biochemistry.
Founder: Ho Leung Ng, PhD.
Former Principal Scientist, Atomwise
Former Professor, Kansas State Univ., Univ. Hawaii
Education: Harvard, UCLA, UC Berkeley
Scientific Advisor: Alan Aspuru-Guzik
Professor, Univ. Toronto
Business Advisor: Vince Feng, Former General Manager, General Atlantic. Cofounder Ocean Arete hedge fund
In addition to our internal drug discovery programs focused on breast cancer, we can partner with you to advance your programs. We are experts in virtual screening, hit-to-lead, and lead optimization.
We are seeking investors to partner with us to accelerate our drug discovery and technology platform programs.
We are USA (SF Bay Area) based and will work with you closely on project goals. Our computational platform is fast and can provide new molecules within a week. We can help you plan molecular design, experiments, and assays.
Berkeley, California, United States